Tel:028-88610620
Email:pr@keymedbio.com/BD@keymedbio.com
Mr. Cheuk Kin Stephen LAW, was appointed as an independent non-executive Director on April 3, 2021. He is responsible for providing independent advice and judgment to our Board.
Mr. Law worked at Wheelock and Company Limited, a company formerly listed on the Stock Exchange (stock code: 0020) and The Wharf (Holdings) Limited, a company listed on the Stock Exchange (stock code: 0004) from 1995 to 2000; Morningside Group from 2000 to 2006; and TPG Growth Capital (Asia) Limited from July 2006 to September 2012, where he last served as a managing director. Mr. Law served as (the chief financial officer of Guoco Group Limited, a company listed on the Stock Exchange (stock code: 0053) from October 2012 to June 2013; (ii) the finance director of MTR Corporation Ltd., a company listed on the Stock Exchange (stock code: 0066) from July 2013 to July 2016; (iii) an adjunct professor of the Hong Kong Polytechnic University from 2015 to 2017; (iv) the independent non-executive director of AAG Energy Holdings Limited, a company listed on the Stock Exchange (stock code: 2686) from July 2016 to September 2018 and (v) an independent non-executive director of Stealth BioTherapeutics Inc., a company listed on NASDAQ (ticker symbol: MITO) from June 2018 to July 2019. He has been the managing director of ANS Capital Limited since 2017.
Mr. Law has been an independent non-executive director of the following companies which are listed on the Stock Exchange: (i) China Everbright Limited (stock code: 0165) since May 2018; (ii) Somerley Capital Holdings Limited (stock code: 8439) since February 2019; (iii) Bank of Guizhou Co., Ltd. (stock code: 6199) since November 2018, (iv) China Galaxy Securities Co., Ltd. (stock code: 06881) since June 2020 and (v) CSPC Pharmaceutical Group Limited (stock code: 1093) since March 2021. Mr.Law is also an independent non-executive director of Bio-Thera Solutions, Ltd. .
Mr. Law obtained his bachelor's degree majoring in science (civil engineering) from University of Birmingham in the United Kingdom in July 1984 and his MBA degree from University of Hull in the United Kingdom in July 1996. Mr. Law was a council member of the Hong Kong Institute of Certified Public Accountants (HKICPA) from January 2010 to December 2017. Mr. Law is now a member of the HKICPA and the Institute of Chartered Accountants in England and Wales, a council member of Hong Kong Business Accountants Association Ltd. (HKBAA) and an expert accounting consultant appointed by the Ministry of Finance in the PRC. Mr. Law is also a council member of The Hong Kong Independent Non-Executive Director Association Limited (HKiNEDA). Mr. Law has accounting qualifications in Hong Kong and the United Kingdom.
Company Profile Management Team Milestones
R&D Center Pipeline Manufacturing Park Cooperation
Corporate Governance Information Disclosure Financial Reports Stock Information IR Calendar Investor Presentations Email Alerts IR Contact
Latest News Media
Culture & Benefits
Contact Information Consultation Legal Statement Privacy
Tel:028-88610620
Email:pr@keymedbio.com/BD@keymedbio.com
蜀ICP备2022006281号